BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31473019)

  • 1. The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?
    Rudnick MR; Leonberg-Yoo AK; Litt HI; Cohen RM; Hilton S; Reese PP
    Am J Kidney Dis; 2020 Jan; 75(1):105-113. PubMed ID: 31473019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
    Chaudhury P; Armanyous S; Harb SC; Ferreira Provenzano L; Ashour T; Jolly SE; Arrigain S; Konig V; Schold JD; Navaneethan SD; Nally JV; Nakhoul GN
    Nephron; 2019; 141(1):31-40. PubMed ID: 30368506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postcontrast Acute Kidney Injury in Pediatric Patients: A Cohort Study.
    McDonald JS; McDonald RJ; Tran CL; Kolbe AB; Williamson EE; Kallmes DF
    Am J Kidney Dis; 2018 Dec; 72(6):811-818. PubMed ID: 30041876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.
    Schönenberger E; Martus P; Bosserdt M; Zimmermann E; Tauber R; Laule M; Dewey M
    Radiology; 2019 Sep; 292(3):664-672. PubMed ID: 31264950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study.
    McDonald JS; McDonald RJ; Williamson EE; Kallmes DF
    Radiology; 2017 Nov; 285(2):414-424. PubMed ID: 28708022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?
    De Simone B; Ansaloni L; Sartelli M; Gaiani F; Leandro G; De' Angelis GL; Di Mario F; Coccolini F; Catena F
    Acta Biomed; 2018 Dec; 89(9-S):158-172. PubMed ID: 30561410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?
    Rachoin JS; Wolfe Y; Patel S; Cerceo E
    Ren Fail; 2021 Dec; 43(1):1311-1321. PubMed ID: 34547972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Induced Nephropathy After Computed Tomography in Stable CKD Patients With Proper Prophylaxis: 8-Year Experience of Outpatient Prophylaxis Program.
    Park S; Kim MH; Kang E; Park S; Jo HA; Lee H; Kim SM; Lee JP; Oh KH; Joo KW; Kim YS; Kim DK
    Medicine (Baltimore); 2016 May; 95(18):e3560. PubMed ID: 27149474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
    Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
    Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.
    McDonald JS; McDonald RJ; Lieske JC; Carter RE; Katzberg RW; Williamson EE; Kallmes DF
    Mayo Clin Proc; 2015 Aug; 90(8):1046-53. PubMed ID: 26250726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study.
    Hirano K; Kobayashi D; Shimbo T; Komatsu Y
    Nephrol Dial Transplant; 2023 May; 38(5):1249-1259. PubMed ID: 36099912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
    Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
    AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
    [No Abstract]   [Full Text] [Related]  

  • 17. The administration of contrast media: is there a risk of acute kidney injury?
    Ferrer Puchol MD; Montesinos García P; Forment Navarro M; Sanz Rodrigo E; Blanco Pérez E; Taberner López E
    Radiologia (Engl Ed); 2019; 61(4):306-314. PubMed ID: 30910216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury After CT in Emergency Patients with Chronic Kidney Disease: A Propensity Score-matched Analysis.
    Kene M; Arasu VA; Mahapatra AK; Huang J; Reed ME
    West J Emerg Med; 2021 Apr; 22(3):614-622. PubMed ID: 34125036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
    Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
    Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.